Repligen
RGEN
#1854
Rank
โ‚ฌ10.05 B
Marketcap
157,30ย โ‚ฌ
Share price
6.47%
Change (1 day)
19.12%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): -0,19ย โ‚ฌ

According to Repligen 's latest financial reports the company's current EPS (TTM) is -0,18ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,79ย โ‚ฌ an increase over its 2024 EPS that were of -0,46ย โ‚ฌ.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,19ย โ‚ฌ-123.67%
20250,79ย โ‚ฌ-270.59%
2024-0,46ย โ‚ฌ-168%
20230,68ย โ‚ฌ-77.68%
20223,06ย โ‚ฌ43.59%
20212,13ย โ‚ฌ105.26%
20201,04ย โ‚ฌ153.33%
20190,41ย โ‚ฌ18.42%
20180,35ย โ‚ฌ-47.95%
20170,67ย โ‚ฌ108.57%
20160,32ย โ‚ฌ20.69%
20150,26ย โ‚ฌ16%
20140,23ย โ‚ฌ-48.98%
20130,45ย โ‚ฌ6.52%
20120,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,65ย โ‚ฌ-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
17,30ย โ‚ฌ-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
7,95ย โ‚ฌ-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-0,35ย โ‚ฌ 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-1,38ย โ‚ฌ 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
6,35ย โ‚ฌ-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
1,07ย โ‚ฌ-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08199ย โ‚ฌ-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
0,93ย โ‚ฌ-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA